179 related articles for article (PubMed ID: 8726012)
1. In vitro synergy testing of macrolide-quinolone combinations against 41 clinical isolates of Legionella.
Martin SJ; Pendland SL; Chen C; Schreckenberger P; Danziger LH
Antimicrob Agents Chemother; 1996 Jun; 40(6):1419-21. PubMed ID: 8726012
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of clarithromycin alone and in combination with ciprofloxacin or levofloxacin against Legionella spp.: enhanced effect by the addition of the metabolite 14-hydroxy clarithromycin.
Martin SJ; Pendland SL; Chen C; Schreckenberger PC; Danziger LH
Diagn Microbiol Infect Dis; 1997 Nov; 29(3):167-71. PubMed ID: 9401809
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility study of BMS-284756 against Legionella species.
Dubois J; St-Pierre C
Diagn Microbiol Infect Dis; 2001; 41(1-2):79-82. PubMed ID: 11687318
[TBL] [Abstract][Full Text] [Related]
4. Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones.
Pendland SL; Martin SJ; Chen C; Schreckenberger PC; Danziger LH
J Clin Microbiol; 1997 Nov; 35(11):3004-6. PubMed ID: 9350781
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila.
Baltch AL; Smith RP; Ritz W
Antimicrob Agents Chemother; 1995 Aug; 39(8):1661-6. PubMed ID: 7486896
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species.
Dubois J; St-Pierre C
Diagn Microbiol Infect Dis; 1999 Apr; 33(4):261-5. PubMed ID: 10212753
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of ninety-eight clinical isolates of Legionella to macrolides and quinolones using the Etest.
Schrock J; Hackman BA; Plouffe JF
Diagn Microbiol Infect Dis; 1997 Aug; 28(4):221-3. PubMed ID: 9327252
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of pazufloxacin, tosufloxacin and other quinolones against Legionella species.
Higa F; Akamine M; Haranaga S; Tohyama M; Shinzato T; Tateyama M; Koide M; Saito A; Fujita J
J Antimicrob Chemother; 2005 Dec; 56(6):1053-7. PubMed ID: 16260445
[TBL] [Abstract][Full Text] [Related]
9. Anti-Legionella activity of trovafloxacin compared with seven other antimicrobial agents including an intermethod evaluation.
Marco F; Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 1997 Sep; 29(1):55-7. PubMed ID: 9350417
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
Visalli MA; Jacobs MR; Appelbaum PC
Diagn Microbiol Infect Dis; 1997 Jul; 28(3):131-7. PubMed ID: 9294703
[TBL] [Abstract][Full Text] [Related]
11. Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing.
Stout JE; Sens K; Mietzner S; Obman A; Yu VL
Int J Antimicrob Agents; 2005 Apr; 25(4):302-7. PubMed ID: 15784309
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp.
Dubois J; St-Pierre C
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():41-6. PubMed ID: 10824031
[TBL] [Abstract][Full Text] [Related]
13. The in-vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results.
Ruckdeschel G; Dalhoff A
J Antimicrob Chemother; 1999 May; 43 Suppl B():25-9. PubMed ID: 10382872
[TBL] [Abstract][Full Text] [Related]
14. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
Stout JE; Arnold B; Yu VL
Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity and resistance of Legionella pneumophila to some antibiotics and combinations of antibiotics.
Moffie BG; Mouton RP
J Antimicrob Chemother; 1988 Oct; 22(4):457-62. PubMed ID: 3204075
[TBL] [Abstract][Full Text] [Related]
16. [Activity of macrolides and fluoroquinolones against intracellular Legionella pneumophila].
Yu LL; Hu BJ; Huang SL; Zhou ZY; Tao LL
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):409-12. PubMed ID: 21781510
[TBL] [Abstract][Full Text] [Related]
17. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp.
Gómez-Lus R; Adrián F; del Campo R; Gómez-Lus P; Sánchez S; García C; Rubio MC
Int J Antimicrob Agents; 2001 Jul; 18(1):49-54. PubMed ID: 11463526
[TBL] [Abstract][Full Text] [Related]
19. Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci.
Spangler SK; Lin G; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1998 May; 42(5):1253-5. PubMed ID: 9593160
[TBL] [Abstract][Full Text] [Related]
20. Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin.
Malanoski GJ; Eliopoulos GM; Ferraro MJ; Moellering RC
Eur J Clin Microbiol Infect Dis; 1993 Feb; 12(2):131-3. PubMed ID: 8388791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
